Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shu-lian Wang, M.D.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator - ye-xiong Li, M.D.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Hospital
Beijing, Beijing Municipality, China
- Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China
- Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
- Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2010
- Primary completion
- 30 Sept 2015
- Completion
- 30 Sept 2018
- Last update posted
- 12 Jan 2026
- Registered enrollment
- 720
- Registry id
- NCT01413269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.